Skip to main content

At the Centre of ANZ’s Pharmacy Industry

Used by 99% of Australian pharmacies and with an expanding footprint in New Zealand, Pharmx is a central to the ANZ pharmacy industry.

Investor Centre - Hero Bananer

Vital Technology Infrastructure

Pharmx (ASX: PHX) technology solutions support and connect pharmacy, supplier, brand, government, and technology partners—including via our exclusive partnership with the National Diabetes Services Scheme (NDSS). As the leading independent pharmacy platform, we’re focused on enhancing healthcare outcomes.

  1. A true market leader: Since launching our supply-chain Gateway in 2006, Pharmx now supports ~$20 billion of business annually and is ANZ’s largest independent pharmacy ordering platform.
  2. Strategic growth: Pharmx is on a mission to provide the most seamless multi-channel pharmacy ordering experience in the world. We’re proud to lead the Australian market and continue expanding rapidly in New Zealand.
  3. Supporting a vital industry: Our technology solutions bring innovation and efficiency to a dynamic industry that’s fueled by population growth, demographic shifts, and regulatory updates.
The most extensive market reach and saturation
Trailblazing the pharmacy industry’s digital transformation
Critical technology supporting a high-growth industry
Tried and tested solutions based on secure, cloud-based tech

Key Announcements & Updates

Pharmx Technologies Ltd. (ASX: PHX) allows investors to play a key role in the pharmacy industry’s digital transformation. Mission-driven, data-powered technology solutions uniquely position PharmX as a pivotal player in the ANZ healthcare market—and we’re proud to lead the way through continued innovation.

Change of Company Secretary
November 28, 2024LEARN MORE
Results of Annual General Meeting
November 26, 2024LEARN MORE
Chairman’s Address & AGM Presentation
November 26, 2024LEARN MORE
Notification of cessation of securities – PHX
November 21, 2024LEARN MORE
Investor Presentation
October 30, 2024LEARN MORE
Notice of Annual General Meeting/Proxy Form
October 25, 2024LEARN MORE
Alternate Director
September 9, 2024LEARN MORE
Initial Director’s Interest Notice
September 9, 2024LEARN MORE
FY24 Results
August 27, 2024LEARN MORE
2024 Annual Report and Appendix 4E
August 27, 2024LEARN MORE
Delay of Results Announcement
August 16, 2024LEARN MORE
Update on Fred Appeals in Legal Proceedings
August 9, 2024LEARN MORE
Letter to Shareholders
August 9, 2024LEARN MORE
Trading Halt
August 8, 2024LEARN MORE
Update Fred Appeal legal proceedings re Corum Systems/PharmX
August 6, 2024LEARN MORE
Ceasing to be a substantial shareholder from AEF
July 31, 2024LEARN MORE
Change in substantial shareholding from AEF
July 30, 2024LEARN MORE
Notice of Results Announcement 30 June 2024
July 24, 2024LEARN MORE
ATO confirms tax implications of return of share capital
July 18, 2024LEARN MORE
Notification regarding unquoted securities – PHX
March 1, 2024LEARN MORE
Half Yearly Report and Accounts
February 23, 2024LEARN MORE
Results Release and Investor Presentation
February 23, 2024LEARN MORE
Appointment of Interim CFO and change of Company Secretary
February 22, 2024LEARN MORE
Change of Director’s Interest Notice – N England
February 16, 2024LEARN MORE
Notice of Results Announcement
February 14, 2024LEARN MORE
Response to ASX Price Query
February 12, 2024LEARN MORE
Capital Return Confirmation
December 5, 2023LEARN MORE
Return of Capital – PHX
November 22, 2023LEARN MORE
Results of Meeting
November 21, 2023LEARN MORE
Chair’s Address to Shareholders
November 21, 2023LEARN MORE
Appointment of Chief Executive Officer
November 15, 2023LEARN MORE
Application for quotation of securities – PHX
October 16, 2023LEARN MORE
Change of Company Name
October 4, 2023LEARN MORE
Completion of sale of pharmacy software business
October 2, 2023LEARN MORE
Results of General Meeting
September 20, 2023LEARN MORE
Appendix 4G and Corporate Governance Statement
August 23, 2023LEARN MORE
FY23 Appendix 4E and Annual Report
August 23, 2023LEARN MORE
FY23 Results Announcement
August 23, 2023LEARN MORE
FY23 Results Investor Presentation
August 23, 2023LEARN MORE
Notice of Extraordinary General MeetingProxy Form
August 18, 2023LEARN MORE
Change of Registered Office
August 14, 2023LEARN MORE
Sale of Corum Pharmacy Software Business
July 21, 2023LEARN MORE
Notification regarding unquoted securities – COO
June 27, 2023LEARN MORE
Further Update on Legal Proceedings
June 5, 2023LEARN MORE
Update on Legal Proceedings
April 21, 2023LEARN MORE
Update on Legal Proceedings relating to PharmX
November 25, 2022LEARN MORE
Chair’s Presentation to the AGM
November 14, 2022LEARN MORE
Amendment to the Constitution
November 14, 2022LEARN MORE
Application for quotation of securities
November 2, 2022LEARN MORE
Notice of Annual General Meeting and Proxy Form
October 12, 2022LEARN MORE
Key AGM Dates
September 13, 2022LEARN MORE
Investor Presentation FY22
September 5, 2022LEARN MORE
Appendix 4E and Annual Report
August 30, 2022LEARN MORE
FY22 Results Release
August 30, 2022LEARN MORE
PharmX Launches PharmXchange Platform
June 22, 2022LEARN MORE
Sigma signs long term PharmX agreement
May 3, 2022LEARN MORE
Notification of cessation of securities – COO
March 30, 2022LEARN MORE
Corum completes sale of Real Estate eCommerce business unit
March 29, 2022LEARN MORE
H1 FY22 Interim Media Release and Results Presentation
February 10, 2022LEARN MORE
PharmX Agreement – Supplementary Information
February 8, 2022LEARN MORE
Symbion & ProPharma sign long term PharmX agreement
February 7, 2022LEARN MORE
Resignation of Managing Director
February 1, 2022LEARN MORE
Final Director’s Interest Notice – J Sallabank
February 1, 2022LEARN MORE
Corum Agrees Sale of eCommerce Business Unit
December 20, 2021LEARN MORE
Trading Update
December 8, 2021LEARN MORE
Chairman & CEO Address and AGM Presentation
November 24, 2021LEARN MORE
Key Retail Pharmacy Groups signed on to drive PharmX growth
November 23, 2021LEARN MORE
Corum Trading Update
October 29, 2021LEARN MORE
Notice of General Meeting/Proxy Form
September 22, 2021LEARN MORE
2021 Annual General Meeting Key Dates
September 10, 2021LEARN MORE
Corum extends relationship with Sigma into WholeLife
September 2, 2021LEARN MORE
Press Release and Investor Presentation
August 18, 2021LEARN MORE
Notice of Results Announcement and Investor Presentation
August 10, 2021LEARN MORE
Quarterly Activity Report and Appendix 4C
July 30, 2021LEARN MORE
Update on Legal Proceedings14 May 2021
May 14, 2021LEARN MORE
Change of Share Registry
April 23, 2021LEARN MORE
Quarterly Activities Report and Appendix 4C
April 22, 2021LEARN MORE
H1 FY21 Interim Media Release and Results Presentation
February 24, 2021LEARN MORE
HY 21 Reporting Date and Investor Presentation
February 17, 2021LEARN MORE
Change of Director’s Interest Notice Newbery
December 15, 2020LEARN MORE
Change of Director’s Interest Notice Shaw
December 10, 2020LEARN MORE
Becoming a substantial holder Bastas
December 9, 2020LEARN MORE
Initial Director’s Interest Notice Bastas
December 9, 2020LEARN MORE
Appointment of Dennis Bastas as Director
December 3, 2020LEARN MORE
Change of Director’s Interest Notice
December 1, 2020LEARN MORE
Proposed issue of Securities – COO
November 19, 2020LEARN MORE
Chairman’s Address to Shareholders
November 17, 2020LEARN MORE
CEO’s Address to Shareholders
November 17, 2020LEARN MORE
Release of ordinary shares from escrow
November 10, 2020LEARN MORE
Appendix 2A
November 6, 2020LEARN MORE
Arrotex Pharmaceuticals becomes strategic shareholder
November 6, 2020LEARN MORE
Cleansing Notice
November 6, 2020LEARN MORE
Corum New Company Secretary Appointment
November 3, 2020LEARN MORE
Appendix 4C – quarterly
October 30, 2020LEARN MORE
Update on BAMM Agreement
October 30, 2020LEARN MORE
Initial director’s Interest Notice
October 20, 2020LEARN MORE
Notice of Annual General Meeting and Explanatory Memorandum
October 16, 2020LEARN MORE
Jayne Shaw Joins Corum Board
October 15, 2020LEARN MORE
Becoming a substantial holder from AEF
October 1, 2020LEARN MORE
2020 Annual General Meeting Update
September 30, 2020LEARN MORE
Cleansing Statement
September 29, 2020LEARN MORE
Completion of $5.6m Capital Raising
September 28, 2020LEARN MORE
Entitlement Offer – Extension of Closing date
September 15, 2020LEARN MORE
Indicative Timetable of Key Dates
September 10, 2020LEARN MORE
Despatch of Offer Booklet
September 9, 2020LEARN MORE
Corum Announces Completion of PharmX Acquisition
September 4, 2020LEARN MORE
Appendix 3Z Final Director’s Interest
September 4, 2020LEARN MORE
Update – Proposed issue of Securities
September 4, 2020LEARN MORE
Corum Executive Management Changes
September 1, 2020LEARN MORE
Acquisition of Remaining 57% interest in PharmX
September 1, 2020LEARN MORE
Offer Booklet
September 1, 2020LEARN MORE
Entitlement Offer Letter to Ineligible Shareholders
September 1, 2020LEARN MORE
Investor Presentation September 2020
September 1, 2020LEARN MORE
Corum Group Annual Report 2020
August 24, 2020LEARN MORE
Appendix 4G & Corporate Governance Statement
August 24, 2020LEARN MORE
Change of Auditor – Audit Practice Restructure
August 21, 2020LEARN MORE
Appendix 3B – Performance Rights Issues
August 21, 2020LEARN MORE
Director Appointment
May 16, 2020LEARN MORE
Director Resignation and Final Director’s Interest Notice
May 6, 2020LEARN MORE
Corum to increase ownership in PharmX
March 24, 2020LEARN MORE
Director Resignation and Final Directors Interest Notice
February 24, 2020LEARN MORE
Chairman Retirement
February 19, 2020LEARN MORE
Final Director’s Interest Notice
February 19, 2020LEARN MORE
Management Incentive Plan
February 18, 2020LEARN MORE
Update on Court Proceedings
December 23, 2019LEARN MORE
Ceasing to be a substantial holder
December 6, 2019LEARN MORE
Board Succession
December 2, 2019LEARN MORE
Appendix 3B – Capital Raise
November 21, 2019LEARN MORE
Change in substantial holding
November 21, 2019LEARN MORE
Cleansing Statement Section708A(5)€
November 21, 2019LEARN MORE
Completion of Share Placement
November 21, 2019LEARN MORE
Investor Group Substantial shareholder notice 603
November 21, 2019LEARN MORE
Chairman’s Address
November 20, 2019LEARN MORE
Ceasing to be Substantial shareholder notice change 605
November 20, 2019LEARN MORE
AGM Results Poll
November 20, 2019LEARN MORE
Waiver From Listing Rule 7.3.2
November 12, 2019LEARN MORE
Addendum to Notice of Annual General Meeting
November 11, 2019LEARN MORE
Appendix 4C Quarterly
October 31, 2019LEARN MORE
Directorship
October 18, 2019LEARN MORE
Notice of Annual General Meeting & Proxy Form
October 18, 2019LEARN MORE
Corum secures strategic partnership
October 11, 2019LEARN MORE
Substantial holder notice
October 8, 2019LEARN MORE
Corum structured for growth
September 27, 2019LEARN MORE
SaaS technolgy collaboration agreement
September 24, 2019LEARN MORE
Results of EGM
February 25, 2019LEARN MORE
Half Yearly Results and Accounts
February 22, 2019LEARN MORE
Half Yearly Results Announcement
February 22, 2019LEARN MORE
Notice of EGM / Proxy Form
February 18, 2019LEARN MORE
Corum Clear Dispense Update
January 26, 2019LEARN MORE
EGM ASX Waiver
January 25, 2019LEARN MORE
AGM Chair and CEO Address
November 28, 2018LEARN MORE
Appendix 4E Preliminary final report
August 29, 2018LEARN MORE
Corum Clear Update
July 20, 2018LEARN MORE
Chairman and CEO Address to Shareholders
November 29, 2017LEARN MORE
Corum signs up to My Health Record
November 29, 2017LEARN MORE
Annual Report to shareholders
October 27, 2017LEARN MORE
Appendix 4G – Corporate Governance
September 1, 2017LEARN MORE
Appendix 4E and Annual Accounts
August 31, 2017LEARN MORE
Corum announces expected non-cash impairment
August 25, 2017LEARN MORE
Half-Year Report Investor Update
January 24, 2017LEARN MORE
Appendix 3B – Exercise of Performance Rights
December 13, 2016LEARN MORE
Chief Executive Officer Appointment
March 11, 2016LEARN MORE
Reinstatement to Official Quotation
February 29, 2016LEARN MORE
Company Update
February 29, 2016LEARN MORE
Suspension from Official Quotation
February 25, 2016LEARN MORE
Appointment of Executive Director
January 11, 2016LEARN MORE
Director Appointment/Resignation
November 2, 2015LEARN MORE
Managing Director / CEO Resignation
October 28, 2015LEARN MORE
Appendix 4G – Key to Corporate Governance Disclosures
October 19, 2015LEARN MORE
FY15 Company Presentation
August 27, 2015LEARN MORE
FY15 Results Announcement
August 27, 2015LEARN MORE
Preliminary Final Report
August 27, 2015LEARN MORE
Director Resignation
August 19, 2015LEARN MORE
Details of Company Address
August 18, 2015LEARN MORE
Appendix 3B – Employee Share Scheme
July 3, 2015LEARN MORE
Managing Director / CEO appointments and contract terms
June 19, 2015LEARN MORE
Performance Rights Lapse
June 5, 2015LEARN MORE
Chairman and Director Appointments
May 20, 2015LEARN MORE
Appendix 4C – quarterly and commentary
April 27, 2015LEARN MORE
Director Appointment / Company Secretary Resignation
April 27, 2015LEARN MORE
Acting MD / CEO – Terms of Appointment
March 19, 2015LEARN MORE
Response to ASX Query
February 24, 2015LEARN MORE
Company Secretary Appointment
February 20, 2015LEARN MORE
Change in Managing Director / Chief Executive Officer
January 30, 2015LEARN MORE
Dividend Declaration
January 28, 2015LEARN MORE
Expiry of Employee Share Options
December 16, 2014LEARN MORE
Appendix 3B – exercise of options
December 15, 2014LEARN MORE
Chairman’s Address to Shareholders
November 19, 2014LEARN MORE
Notice of General Meeting / Proxy Form
October 17, 2014LEARN MORE